# Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects

> **NCT04131595** · PHASE1 · COMPLETED · sponsor: **Bavarian Nordic** · enrollment: 45 (actual)

## Conditions studied

- Equine Encephalitis

## Interventions

- **BIOLOGICAL:** MVA-BN-WEV Dose 1
- **BIOLOGICAL:** MVA-BN-WEV Dose 2
- **BIOLOGICAL:** MVA-BN-WEV Dose 3

## Key facts

- **NCT ID:** NCT04131595
- **Lead sponsor:** Bavarian Nordic
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-07
- **Primary completion:** 2020-07-22
- **Final completion:** 2020-07-22
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2020-08-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04131595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04131595, "Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04131595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*